Log In
Print this Print this

Chuanqing, ligustrazine

  Manage Alerts
Collapse Summary General Information
Company Sihuan Pharmaceutical Holdings Group Ltd.
DescriptionCalcium channel blocker
Molecular Target Calcium channel
Mechanism of ActionCalcium channel blocker
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationCoronary artery disease (CAD)
Indication DetailsTreat coronary artery disease (CAD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today